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Abstract 
Background: There is a developing body of research looking at cannabis use opportunity, 
but little research examining timing of opportunity to use cannabis. 
Aims: Identify factors associated with 1) earlier opportunity to use cannabis and 2) faster 
progression from opportunity to cannabis dependence. 
Method: Cross-sectional study of 3824 Australian twins and siblings, measuring age of onset 
of cannabis use opportunity and DSM-IV cannabis dependence. Survival analysis identified 
factors associated with faster progression to opportunity or dependence. 
Results: Factors associated with both speed of progression to opportunity and dependence 
were conduct disorder (opportunity HR 5.57, 95%CI 1.52-20.47; dependence HR 2.49, 
95%CI 1.91-3.25), parental drug problems (opportunity HR 7.29, 95%CI 1.74-30.62; 
dependence HR 3.30, 95%CI 1.63-6.69), weekly tobacco use (opportunity HR 8.57, 95%CI 
3.93-18.68; dependence HR 2.76, 95% CI 2.10-3.64), and female gender (opportunity HR 
0.69, 95%CI 0.64-0.75; dependence HR 0.44, 95%CI 0.34-0.55). Frequent childhood 
religious attendance (HR 0.74, 95%CI 0.68-0.80), parental conflict (HR 1.09, 95%CI 1.00-
1.18), parental alcohol problems (HR 1.19, 95%CI 1.08-1.30) and childhood sexual abuse 
(HR 1.17, 95%CI 1.01-1.34) were uniquely associated with transition to opportunity. 
Depressive episode (HR 1.44, 95%CI 1.12-1.85), tobacco dependence (HR 1.36, 95%CI 1.04 
– 1.78), alcohol dependence (HR 2.64, 95%CI 1.53-4.58), other drug use (HR 2.10, 95%CI 
1.64-2.69) and other drug dependence (HR 2.75, 95%CI 1.70-4.43) were uniquely associated 
with progression to dependence. 
Conclusion: The profile of factors associated with opportunity to use cannabis and 
dependence only partially overlaps, suggesting targeting of interventions may benefit from 
being tailored to the stages of drug use. 
 
Keywords: Cannabis, Opportunity, Dependence, Transitions, Substance Use, Survival 
Analysis, Risk Factors, Etiology  
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Introduction 
Cannabis is widely used, with cumulative lifetime incidence of use estimated to range from 
6%-20% in Europe, 3%-11% in the Middle East and Africa, and exceeding 40% in the US 
and New Zealand (Degenhardt et al., 2008). Lifetime prevalence of cannabis use in 
Australian adolescents has been estimated at 60% (Patton et al., 2002).  Although many 
individuals use cannabis infrequently and without experiencing problems, globally an 
estimated 13.1 million individuals meet criteria for cannabis dependence, contributing 10.3% 
of the illicit drug use global burden of disease (Degenhardt et al., 2014). It is estimated 10% - 
16% of cannabis users develop dependence (Anthony, 2006), but before progressing to 
dependence individuals must pass through a number of preceding stages. Examining the 
multiple stages of drug use before dependence develops is necessary for gaining a 
comprehensive understanding of factors involved in drug use, and for identifying 
opportunities for early intervention (Hines et al., 2015a).  
 
The first stage of drug involvement is having the opportunity to use (regardless of whether 
the individual uses the drug or not), which forms the “exposure opportunity” in the 
epidemiology of drug use (Wagner and Anthony, 2002). Opportunity is required for use to 
occur, and forms an individual’s earliest necessary condition from which they are at risk of 
developing cannabis dependence.  Recent research indicates the majority of adolescents 
who have an opportunity to use cannabis progress to initiation of use (Caris et al., 2009; 
Lopez-Quintero and Neumark, 2015; Pinchevsky et al., 2011), making the opportunity to use 
an important target for intervention (Neumark et al., 2012).  
 
There is a developing body of research looking at the opportunity to use. Factors associated 
with opportunity to use cannabis include using alcohol, using tobacco and the combination of 
alcohol and tobacco use (Caris et al., 2009; Neumark et al., 2012; Wagner and Anthony, 
2002). In Chile and the US, males have been found to be slightly more likely than females to 
have a chance to use cannabis (Caris et al., 2009; Van Etten and Anthony, 1999), but these 
gender differences have not been consistently observed (Wells et al., 2011). Childhood 
religious practices are associated with decreased likelihood of cannabis use opportunity 
(Chen et al., 2004), and those with externalising behaviour problems have been found to be 
more likely to have a cannabis use opportunity (Neumark et al., 2012; Reboussin et al., 
2015). Perhaps unsurprisingly given that first cannabis use opportunity typically occurs in 
late childhood or early adolescence, lower parental involvement and higher levels of 
coercive discipline have been found to be associated with increased likelihood of cannabis 
use opportunity (Chen et al., 2005). The effect of parenting continues throughout 
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adolescence, with those who reported low parental monitoring in high school more likely to 
have cannabis use opportunity once they started college (Pinchevsky et al., 2011).  
 
Amongst this existing evidence, there is little research examining the timing of opportunity to 
use cannabis. The study of transitions, and the timing of these transitions, can provide 
unique insights into influences on substance use (Behrendt et al., 2012; Hines et al., 2015b; 
Sartor et al., 2009, 2008), but only a limited  number of factors have been studied in relation 
to speed of transition to cannabis use opportunity (with earlier opportunity representing a 
faster transition) These have focussed on early childhood behaviours, with  disruptive 
behaviour early in school in males and better reading scores in females associated with 
earlier cannabis use opportunity (Storr et al., 2011). Similarly, no research to date has 
explored whether there is overlap between factors associated with earlier opportunity and 
those associated with the speed of progression to dependence. These include other 
substance use (Behrendt et al., 2009), some mental health factors (Behrendt et al., 2011) 
and gender (Ridenour et al., 2006; Wittchen et al., 2008). Exploring speed of transition to 
cannabis opportunity  will determine whether risk factors for dependence are already 
exerting influence on drug use behaviours at the start of an individual’s cannabis 
involvement, which has utility for improving understanding of how dependence develops 
(Hines et al., 2015a). Applying survival analysis methodology to this area allows for 
quantification of time to cannabis use opportunity and from opportunity to dependence, and 
identification of what factors may impact upon the speed of these transitions. 
 
This paper aims to: 
1. Identify factors associated with earlier opportunity to use cannabis  
2. Identify factors associated with progression from cannabis use opportunity to 
cannabis dependence 
3. Determine whether factors associated with opportunity to use cannabis are also 
associated with more rapid progression from first opportunity to dependence.  
 
Methods  
2.1 Sample 
The sample was drawn from the Australian Twin Registry. From a pool of twin pairs born 
between 1972 – 1979, 3348 MZ and DZ twins and 476 of their siblings (mean age at time of 
interview = 32.1, SD 3.04, range 21-46) completed the interview component of a study of 
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cannabis and other drug misuse. A full description of the study methodology and of the 
characteristics of participants has been published previously (Lynskey et al., 2012). 
 
2.2 Assessment 
Participants were assessed through computer-assisted telephone interviews which collected 
information on socio-demographics, childhood experiences, drug use and common mental 
health disorders, including conduct disorder and major depressive disorder, assessed using 
the SSAGA-OZ interview (Bucholz et al., 1994; Heath et al., 1997). The SSAGA-OZ is a 
validated measure of mental health using DSM-IV criteria, and includes assessment of 
cannabis and other drug abuse and dependence. Specific measures used in the current 
analyses are described below. 
2.3 Measures 
2.3.1 Outcome Measures 
Opportunity to use cannabis 
Participants were asked “have you ever been offered, or had the opportunity to use 
cannabis, even if you didn't use it at the time? How old were you the first time?” Of 3824 
individuals interviewed, 3798 provided information on whether or not they had ever had the 
opportunity to use cannabis. Of these, 85% (N=3399) reported  
they had an opportunity to use cannabis. A continuous measure of age of first opportunity 
was used for both survival analysis models.  
 
Cannabis dependence 
Participants were classified as meeting lifetime criteria for DSM-IV cannabis dependence 
(American Psychiatric Association, 2000) if they reported three or more of the following 
symptoms occurring within the same 12 month period:  using cannabis a greater number of 
times/greater amount than was intended, tolerance, wanting to cut down/stop use, spending 
so much time obtaining/using/recovering from the effects of cannabis the participant had little 
time for anything else, reducing important activities as a result of cannabis use, continuing 
use despite it worsening health/emotional problems. Withdrawal was not included as it was 
not part of DSM-IV criteria for cannabis dependence. Participants were also asked the age 
at which they first experienced three or more of these symptoms occurring within a 12 month 
period. 
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Of those reporting lifetime opportunity to use cannabis, 10.9% (N=371) met criteria for 
cannabis dependence, and a continuous measure of age at onset of cannabis dependence 
was used in survival analysis.  
2.3.2 Covariates 
Demographic characteristics 
Gender was determined through self-report. 
 
Childhood and parenting factors 
Parental alcohol problems were determined through participant self-report of their mother or 
father experiencing problems with health/family/job/police/other as a result of drinking, or 
their mother or father drinking excessively. 
Parental drug problems were determined through participant self-report of their mother or 
father experiencing problems with health/family/job/police/other as a result of drug use, or 
the participant reporting they felt their mother or father had a problem with drugs. 
Parental conflict was determined by participant responses to the questions “how often did 
your parents fight or argue in front of you?” and “how much conflict and tension was there 
between your parents?” Both questions focused on the period when the participant was 
aged 6 – 13. Participants reporting parents ‘sometimes’ or ‘always’ fought or argued or ‘a lot’ 
or ‘some’ conflict/tension were coded as experiencing high parental conflict. 
 
Single parent family was determined by participants’ report of whether their mother or father 
was absent. Interviewers recorded whether participants lived with their mother/mother figure 
and/or their father/father figure for at least 4 full years between 6 and 13. 
 
Strict parenting was determined through participants response to the items “In your opinion, 
when you were 6 to 13, was your mother/mother figure more strict than most mothers?” and 
“ In your opinion, when you were 6 to 13, was your father/father figure more strict than most 
fathers?”.  Those who endorsed either of these items were classified as having experienced 
strict parenting. 
 
Childhood sexual abuse was recorded for individuals who reported being forced into sexual 
intercourse or any other forms of sexual activity before age 18. Self-reported age of sexual 
abuse onset was used to create a time varying covariate for sexual abuse. 
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Frequent childhood religious attendance was determined through participant self-report of 
their frequency of attendance at religious services between ages 6 and 13. Participants were 
coded as frequently attending religious services if they reported attendance more than once 
a week, once a week, once or twice a month or every couple of months.  
Mental health 
Conduct disorder was determined by participant self-report of at least 3 of the 15 DSM-IV 
criteria (American Psychiatric Association, 2000) occurring within the same 12-month period, 
prior to age 18. Participants’ self-reported age of onset of 3 symptoms occurring within a 12 
month period was used to create a time varying covariate for conduct disorder. 
 
Depressive episode was recorded if participants reported a two week period where they 
were more irritable than usual (if under age 18 at the time), felt 
depressed/down/sad/blue/discouraged, or had a lot less interest in things. Self-reported age 
of the first occurring depressive episode was used to make time varying covariates for 
survival analysis.  
Other substance use 
Weekly tobacco use was measured through the interview item “Was there ever a time in 
your life when you smoked cigarettes at least once a week for at least two months in a row?” 
Self-reported age of onset of weekly tobacco use was used to make time varying covariates 
for survival analysis. 
Tobacco dependence was measured through participants reporting 3 or more of the DSM-IV 
tobacco dependence criteria (American Psychiatric Association, 2000) occurring within a 12 
month period. Self-reported age of onset of tobacco dependence was used to make time 
varying covariates for survival analysis. 
 
Monthly alcohol use was measured through the interview item “At what age did you start to 
drink regularly - that is, drinking at least once a month for 6 months or more?” Self-reported 
age of onset of monthly alcohol use was used to make time varying covariates for survival 
analysis. 
Alcohol dependence was measured through participants reporting 3 or more of the DSM-IV 
alcohol dependence criteria (American Psychiatric Association, 2000) occurring within a 12 
month period. Self-reported age of onset of alcohol dependence was used to make time 
varying covariates for survival analysis. 
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Other drug use was recorded if participants reported lifetime non-prescribed use of any of 
the following: cocaine (all forms), stimulants, opiates and major painkillers, sedatives, 
hallucinogens, dissociatives, solvents or inhalants. Self-reported age of drug use onset was 
used to create a time varying covariate for first other drug use. 
 
Other drug dependence was recorded if participants reported lifetime dependence on any of 
the following: cocaine (all forms), stimulants, opiates and major painkillers, sedatives, 
hallucinogens, dissociatives, solvents and inhalants. Participants were classified as meeting 
lifetime criteria for DSM-IV drug dependence if they reported 3 or more of the 7 DSM-IV 
symptoms of dependence (American Psychiatric Association, 2000) occurring within the 
same 12 month period. Self-reported age of onset of dependence was used to create a time 
varying covariate for other drug dependence. This covariate was only included in the model 
of progression to the development of dependence. 
 
2.4 Statistical analyses 
All analyses were conducted in Stata statistical software version 11 (StataCorp, 2009). 
Two separate Cox proportional hazard models were fitted to the data to test the association 
between a number of potential associated factors and speed of progression from (1) birth to 
opportunity to use cannabis and (2) opportunity to use cannabis to the development of 
cannabis dependence.   Both were assessed as time in years. Details of the two Cox 
Proportional Hazards models are provided below: 
Model one: To identify factors associated with hazard of the opportunity to use cannabis 
survival data (time in years, starting from birth) were used for analysis of 3798 participants 
who had provided information on opportunity to use cannabis. Failure event was opportunity 
to use cannabis, and 3398 failure events were observed (one participant was excluded from 
analysis, see description below). Due to missing covariate data, 3763 participants were 
included in the final model (3367 failure events). 
Model two: To identify factors associated with hazard of the development of dependence 
following the opportunity to use cannabis survival data (time in years, starting from age of 
first opportunity to use cannabis) were used for analysis of 2593 participants who had 
reported their age of opportunity to use cannabis and who had also reported lifetime 
cannabis use (those who had not reported lifetime cannabis use were removed from the 
model in order to avoid the inverse association that would exist between never-use of 
cannabis and cannabis dependence; additionally, one participant was omitted as their 
recorded age of dependence was earlier than recorded age of opportunity). The failure event 
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was cannabis dependence, and 371 failures were observed. Due to missing covariate data, 
2565 participants were included in the final model (363 failure events). 
Person year data sets were constructed providing a separate row of participant data for each 
year from birth for model 1, and for each year from age of opportunity for model 2. In order to 
account for multiple participants experiencing failures events in the same year, the Efron 
adjustment for survival ties (Efron, 1977) was applied.  Participants were right-censored at 
age of interview.  
Factors described above were included the model.  Time varying measures were produced 
for conduct disorder, monthly alcohol use, alcohol dependence, weekly tobacco use, 
tobacco dependence, other drug use, other drug dependence, childhood sexual abuse, and 
depressive episode. These variables were coded as present for each year after the age of 
onset, and were only included in the model if they were positive prior to the onset of 
cannabis use opportunity for model one, or prior to the onset of dependence for model two 
(e.g. if age at opportunity to use cannabis was 13, then conduct disorder with an age of 
onset of 14 was coded as absent prior to the onset of opportunity).  
To minimise the likelihood that the effect of childhood covariates where the specified time 
periods were ages 6 – 13 (parental conflict, single parent family, strict parenting, frequent 
childhood religious attendance) may have occurred after the point of cannabis use 
opportunity, any individuals who reported use opportunity before the age of 6 were removed 
from model one. This resulted in the observations of only one participant being removed 
from the model. Huber-White analysis for clustered data was implemented to adjust for the 
non-independence of observations from members of a twin pair. The assumption of 
proportional hazards was assessed through tests of Schoenfeld residuals and modelling of 
the interaction of covariates with time in the analysis (represented as ‘_t’)  (P=≤0.05). Any 
variables found to violate the proportional hazards assumption were reparameterized via 
modelling interactions between the variable and time in the analysis, resulting in an 
extended Cox Proportional Hazards model.  
Analyses on the transition from opportunity to first use of cannabis could not be conducted 
due to insufficient variation in this measure (the majority of participants progressed from 
opportunity to first use 0 or 1 years after having the opportunity to use, data available on 
request). 
Results 
3.1 Sample, Survival Data and the Proportional Hazards Assumption 
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Comparisons between those who did and did not report lifetime cannabis use opportunity, 
and those who did and did not progress to cannabis use following opportunity, show these 
groups differ on the majority of the covariates tested within the survival models (see Table 1 
and 2). Mean age of first cannabis use opportunity was 17.6 (s.d. 3.2) and the mean age of 
cannabis dependence 21.4 (s.d. 4.1). The mean survival time for the participants in the 
cannabis use opportunity model was 19.1 years (s.d. 5.1) (age at opportunity, or for those 
who did not report opportunity, age at interview. This figure is higher than the mean 
opportunity age as individuals who have not experienced opportunity by the point of 
interview are also included in the survival model, with their age at time of interview in place 
of age of opportunity). The mean survival time for participants in the cannabis dependence 
model was 13.4 years (s.d. 4.9) (time from opportunity to dependence, or for those who did 
not develop dependence, time from opportunity to age at interview). This figure is higher 
than may be expected from the mean dependence age as individuals who have not 
developed dependence by the point of interview are also included in the survival time, with 
their time from opportunity to age at interview in place of time to dependence. 
All covariates were tested for breach of the proportional hazards assumption, as outlined in 
the methods section. The following did not satisfy the proportional hazards assumption for 
the opportunity to use model and therefore the interaction term between the factor and 
analysis time was modelled in the cannabis use opportunity analysis (Bellera et al., 2010): 
conduct disorder, parental drug problems, weekly tobacco use and monthly alcohol use. 
Similarly, for the cannabis dependence analysis the following variables had the interaction 
with analysis time modelled in the analysis: parental drug problems, alcohol dependence 
and other drug use. 
3.2 Factors Associated with Opportunity to Use Cannabis 
Results from the Cox proportional hazards model for transition to opportunity to use 
cannabis are presented in Table 3. Conduct disorder, high parental conflict, parental alcohol 
problems, parental drug problems, childhood sexual abuse and weekly tobacco use were 
associated with increased hazard of earlier opportunity to use cannabis. Frequent childhood 
religious attendance and female gender were independently associated with slower 
transition to cannabis use opportunity. 
 
3.3 Factors Uniquely Associated with Progression to Cannabis Dependence 
Results from the Cox proportional hazards model for transition from opportunity to use 
cannabis to dependence are presented in Table 3. Conduct disorder, parental drug 
problems, weekly tobacco use, depressive episode, tobacco dependence, alcohol 
dependence, other drug use and other drug dependence were associated with increased 
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hazard of faster transition cannabis dependence. Female gender was independently 
associated with slower transition to cannabis dependence.  
3.4 Factors Consistently Associated Across Transitions  
Factors associated with increased hazard of both earlier cannabis use opportunity and faster 
progression to cannabis dependence were conduct disorder, parental drug problems, and 
weekly tobacco use (see Table 3). Female gender was associated with slower progression 
to both cannabis use opportunity and dependence. 
 
Discussion 
This paper identifies a number of factors uniquely associated with the transition to cannabis 
use opportunity and with the transition from opportunity to cannabis dependence, and several 
factors that increase hazards of both these transitions. Parental conflict, parental alcohol 
problems and childhood sexual abuse were uniquely associated with faster transition to 
opportunity, whilst frequent childhood religious attendance was associated with slower 
transition to opportunity. Depressive episode, tobacco dependence, alcohol dependence, 
other drug use and other drug dependence were uniquely associated with faster progression 
from opportunity to dependence. Conduct disorder, parental drug problems and weekly 
tobacco use were associated with faster progression to both opportunity and from opportunity 
and dependence, with female gender associated with slower transition for both. 
 
Exploring a broad range of factors has identified similarities and inconsistencies with the 
existing literature.  Frequent  childhood religious attendance, associated with reduced 
likelihood of cannabis use opportunity, was consistent with existing literature (Chen et al., 
2004). In contrast to prior literature (Miller et al., 2000) this protective effect did not extend to 
dependence. Depressive episode was associated with increased speed of transition to 
dependence, which is consistent with emerging findings of an association between 
depression and cannabis use disorders (Feingold et al., 2015; Pacek et al., 2013), but was 
not found to be associated with earlier opportunity to use cannabis. This may be due to the 
age of depressive episode onset occurring after age of cannabis use opportunity for the 
majority of participants. Previous research has reported that childhood adversity and sexual 
abuse are associated with other drug use opportunity and cannabis dependence (Benjet et 
al., 2013; Duncan et al., 2008) but, while the present analyses identified an association 
between childhood sexual abuse and earlier cannabis use opportunity, there was no 
association between childhood sexual abuse and progression from opportunity to 
dependence. Differences between the present findings and existing research may be due to 
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the relatively novel exploration of speed of transitions between stages rather than the 
likelihood of outcomes, which has been the focus of much existing research. 
 
The identification of tobacco, alcohol and other drug involvement as factors associated with 
progression from opportunity to dependence suggests that a pattern of poly-use emerges. 
Although alcohol use has previously been found to be associated with early onset of 
cannabis use (Coffey et al., 2000) it was not associated with opportunity to use cannabis in 
the present analyses, which may partially reflect the high prevalence of monthly alcohol use 
in the current sample. The comparatively rarer outcomes of tobacco dependence, other drug 
use and other drug dependence were found to be associated with increased speed of 
progression to cannabis dependence. The use of both tobacco and cannabis has been 
frequently observed (Agrawal et al., 2012, 2010; Hindocha et al., 2015), and regular 
cigarette smokers are more likely to report earlier cannabis use opportunity (Agrawal et al., 
2013). Present results strongly supported this finding, and extend it to show weekly tobacco 
use and dependence were significantly associated with speed of progression to cannabis 
dependence. The observed association between cannabis dependence & tobacco may be 
due to a number of factors including shared genetic and environmental influences, the co-
administration of tobacco and cannabis, and smoking habituation (Agrawal et al., 2012). 
 
A number of factors were associated with both transitions studied. Female gender was 
associated with slower progression to both opportunity and dependence. It is interesting to 
note that gender differences held across both transitions given that previous research has 
found males more likely to have opportunity to use cannabis, but has found these gender 
differences do not extend to the transition into drug use once opportunity has occurred (van 
Etten et al., 1999). Similarly, weekly tobacco use was associated with increased hazard of 
both cannabis use opportunity and progression to cannabis dependence, consistent with 
existing findings relating to dependence (Wagner and Anthony 2002). Conduct disorder was 
associated with faster progression to both opportunity and dependence, echoing previous 
research showing disruptive or aggressive behaviour in both males and females is 
associated with earlier opportunity to use cannabis (Storr et al., 2011). Parental drug 
problems were significantly associated with a more rapid transition to both opportunity and 
dependence, in line with existing research relating to opportunity (Benjet et al., 2013). This 
factor most clearly demonstrated changes in the magnitude of effect size between 
transitions, and given the especially strong association with opportunity to use cannabis it is 
plausible that parental drug problems facilitate an environment in which drug access is 
increased, whether this is indirectly or directly through parents. Alternatively, cannabis 
availability has previously been shown to be influenced by genetic effects (Gillespie et al., 
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2009), and the present finding may represent a genetic liability to creating drug use 
opportunities. 
The pattern of results presented in this paper demonstrates that the influence of factors 
differs throughout the stages of drug use progression. Research relating to early onset of 
drug use often calls for earlier detection and intervention (Chen et al., 2009), and the current 
findings have two key implications for prevention. Firstly, as factors play different roles 
across drug involvement, interventions may benefit from tailoring to stages of drug use. 
Secondly, targeting of interventions may improve by considering the consistency and 
differences in associated factors across the stages of drug use. Using the results of the 
present study may facilitate identification of populations who will benefit from targeted or 
indicated prevention strategies (National Research Council (US) and Institute of Medicine 
(US) Committee on the Prevention of Mental Disorders and Substance Abuse Among 
Children, Youth, and Young Adults: Research Advances and Promising Interventions, 2009). 
There are certain considerations required in interpretation of this work. Firstly, analyses were 
conducted on retrospective self-report data, introducing the possibility of recall bias. This is a 
viable method of data collection (Darke, 1998; Sartor et al., 2011), and indeed recall of early 
experience with cannabis has been found to be especially reliable (Johnson and Mott, 2001), 
but as the analyses rely on accurate recall of age of onset of a number of behaviours the 
work would benefit from replication in longitudinal cohorts. Secondly, analyses of the 
progression from opportunity to cannabis use initiation were not possible, as timing of 
transitions was only available as time in years, and there was not enough variation in the 
speed of this transition to allow for analysis (the majority of participants progressed to use 
within 1 year after having the opportunity to use, data available on request). Thirdly, selected 
covariates measured occurrence within an age range (6-13), and consequently may have 
occurred prior to the age of opportunity to use cannabis for a small number of individuals. 
Fourthly, while the prevalence of lifetime cannabis use in this sample was relatively high at 
68.2% (Lynskey et al., 2012) it is important to note this estimate is consistent with previous 
estimates from the Australian young adult population (Australian Institute of Health and 
Welfare, 2014). Finally, interpretation of these analyses should be in light of the twin and 
sibling sample used, as there is some residual uncertainty about whether inferences from 
twin data have external validity with respect to what might be found in general population 
samples (Vitaro et al., 2009). Analyses were adjusted for clustering effects using the Huber-
White estimator, which was selected over other potential analyses that can be conducted to 
explore within twin/sibling frailties as the most parsimonious method.  
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Conclusions 
Consideration of multiple stages of drug use from non-use to dependence allows 
identification of factors uniquely associated with specific transitions. The current results 
demonstrate that different factors are influential at different stages of the development of 
cannabis dependence. Additionally, the differences and consistencies in factors across the 
stages of drug use provide an insight into which similarities and differences we may expect 
to see occurring through the transitions towards dependence. The findings have implications 
for substance use prevention efforts, as both the targeting of interventions as well as the 
interventions themselves may benefit from being tailored to stages of drug use. 
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Table 1: Comparison of Characteristics of those who reported no lifetime cannabis use opportunity with those who reported lifetime 
cannabis use opportunity, and those who reported cannabis use opportunity and did not progress to use with those who did 
progress to use (Proportions and Odds Ratios) 
 
 
 No opportunity to 
use cannabis 
N = 399 
N (%) 
Opportunity to 
use cannabis 
N = 3399 
N (%) 
Odds Ratio  
(95% CI) 
Opportunity but 
did not initiate 
cannabis use 
N = 805 
N (%) 
Opportunity and 
initiated cannabis 
use 
N = 2593 
N (%) 
Odds Ratio  
(95% CI) 
Female Gender 
 
326 (81.7) 2099 (61.8) 0.36  
(0.28 – 0.47) 
535 (66.5) 1563 (60.3) 0.77  
(0.65 – 0.91) 
Conduct Disorder 
 
4 (1.0) 320 (9.4) 10.30 
(3.82 – 27.76) 
24 (2.98) 296 (11.4) 4.21 
(2.76 – 6.43) 
Depressive 
Episode 
185 (46.5) 1636 (48.3) 1.08 
(0.87 – 1.32) 
374 (46.5) 1262 (48.9) 1.10 
(0.94 – 1.29) 
High Parental 
Conflict† 
128 (32.1) 1272 (37.4) 1.27 
(1.02 – 1.58) 
257 (31.9) 1015 (39.2) 1.37 
(1.16 – 1.62) 
Parental Alcohol 
Problems 
57 (14.3) 895 (26.3) 2.15 
(1.61 – 2.87) 
183 (22.7) 712 (27.5) 1.29  
(1.07 – 1.55) 
Parental Drug 
Problems 
5 (1.3) 125 (3.7) 3.03 
(1.23 – 7.46) 
19 (2.36) 106 (4.1) 1.78  
(1.09 – 2.92) 
Single Parent 
Family†  
 
14 (3.5) 203 (6.0) 1.75 
(1.01 – 3.03) 
48 (6.0) 155 (6.0) 1.00  
(0.72 – 1.40) 
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Strict Parenting†  
 
183 (45.9) 1672 (49.2) 1.14 
(0.93 – 1.41) 
371 (46.1) 1301 (50.3) 1.18 
(1.01 – 1.38) 
Frequent 
Childhood 
Religious 
Attendance† 
299 (74.9) 1981 (58.3) 0.47 
(0.37 – 0.59) 
512 (63.6) 1468 (56.6) 0.75 
(0.63 – 0.88) 
Childhood Sexual 
Abuse 
20 (5.1) 303 (9.0) 1.86 
(1.17 – 2.95) 
48 (6.0) 255 (9.9) 1.73 
(1.26 – 2.38) 
Weekly Tobacco 
Use 
30 (7.5) 1493 (44.0) 9.65 
(6.61 – 14.09) 
110 (13.7) 1382 (53.4) 7.23  
(5.83 – 8.96) 
Tobacco 
Dependence 
15 (3.8) 946 (27.8) 9.89 
(5.87 – 16.65) 
50 (6.2) 895 (34.5) 7.97 
(5.92 – 10.73) 
Monthly Alcohol 
Use 
274 (68.7) 3182 (93.6) 6.72 
(5.22 – 8.65) 
682 (84.7) 2500 (96.5) 4.90 
(3.69 – 6.51) 
Alcohol 
Dependence 
19 (4.8) 928 (27.3) 7.51 
(4.71 – 11.98) 
85 (10.6) 843 (32.5) 4.08 
(3.21 – 5.18) 
Other Drug use 49 (12.3) 1623 (47.8) 6.54 
(4.81 – 8.88) 
140 (17.4) 1483 (57.2) 6.36 
(5.21 – 7.75) 
Other Drug 
Dependence 
0 (0.0) 178 (5.2) - 5 (0.6) 173 (6.7) 11.51  
(4.71 – 28.10) 
 
† When participant was aged 6 – 13 years old. 
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Table 2: Mean age (standard deviation) of behaviour onsets of those who reported no lifetime cannabis use opportunity with those 
who reported lifetime cannabis use opportunity, and those who reported cannabis use opportunity and did not progress to use with 
those who did progress to use  
 
 
 No opportunity to 
use cannabis 
N = 399 
 
Opportunity to 
use cannabis 
N = 3399 
 
Opportunity but 
did not initiate 
cannabis use 
N = 805 
 
Opportunity and 
initiated cannabis 
use 
N = 2593 
 
Conduct Disorder 
 
12.5 (s.d. 4.20) 14.2 (s.d. 2.31) 
 
14.0 (s.d. 2.88) 14.2 (s.d. 2.26) 
Depressive 
Episode 
22.4 (s.d. 6.26) 21.8 (s.d. 6.42). 21.8 (s.d. 6.51) 21.8 (s.d. 6.40) 
Childhood Sexual 
Abuse 
11.9 (s.d. 4.56) 11.1 (s.d. 4.68) 10.2 (s.d. 4.58) 11.3 (s.d. 4.69) 
Weekly Tobacco 
Use 
17.2 (s.d. 2.64) 17.3 (s.d. 3.44). 18.3 (s.d. 3.58) 17.3 (s.d. 3.42) 
Tobacco 
Dependence 
23.8 (s.d. 7.77) 21.9 (s.d. 4.47). 23.5 (s.d. 4.62) 21.8 (s.d. 4.45) 
Monthly Alcohol 
Use 
20.4 (s.d. 3.72) 18.0 (s.d. 2.57). 19.1 (s.d. 3.14) 17.7 (s.d. 2.31) 
Alcohol 22.6 (s.d. 4.79) 22.5 (s.d. 4.20). 22.7 (s.d. 4.27) 22.5 (s.d. 4.19) 
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Dependence  
Other Drug use 23.7 (s.d. 6.20) 21.6 (s.d. 4.26) 21.9 (s.d. 5.45) 21.6 (s.d. 4.13) 
Other Drug 
Dependence 
0 (0.0) 23.0 (s.d. 4.52) 25.8 (s.d. 3.90) 22.9 (s.d. 4.52) 
 
 
 
Table 3: Hazard ratios (95%CI) from Cox Regression Models: Factor Associated with Earlier Opportunity to Use Cannabis, and for 
Progression from Opportunity to Use Cannabis to Cannabis Dependence 
Covariate Transition to Cannabis Use Opportunity 
N = 3763 
Transition to Cannabis Dependence  
N = 3367 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
Female Gender 
 
0.70*** 
(0.65 – 0.75) 
0.69*** 
(0.64-0.75) 
0.50*** 
(0.40 – 0.62) 
0.44*** 
(0.34-0.55) 
Conduct Disorder1 
 
27.54*** 
(2.39 – 23.76) 
25.57** 
(1.52-20.47) 
4.57*** 
(3.63 – 5.75) 
2.49*** 
(1.91-3.25) 
Depressive Episode1 
 
1.04 
(0.93 - 1.17) 
0.98 
(0.87-1.10) 
1.95*** 
(1.55 - 2.42) 
1.44*** 
(1.12-1.85) 
High Parental Conflict† 
 
1.09* 
(1.01 – 1.18) 
1.09* 
(1.00-1.18) 
1.16 
(0.94 – 1.44) 
1.02 
(0.79-1.31) 
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Covariate Transition to Cannabis Use Opportunity 
N = 3763 
Transition to Cannabis Dependence  
N = 3367 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
Parental Alcohol Problems 
 
1.27*** 
(1.16 – 1.38) 
1.19*** 
(1.08-1.30) 
1.29** 
(1.03 – 1.62) 
1.11 
(0.86-1.43) 
Parental Drug Problems 
 
28.26** 
(2.12 – 32.15) 
27.29** 
(1.74-30.62) 
24.14*** 
(2.07 – 8.27) 
23.30*** 
(1.63-6.69) 
Single Parent Family† 
 
1.30** 
(1.10 – 1.53) 
1.13 
(0.95-1.35) 
1.60* 
(1.11 - 2.32) 
1.19 
(0.78-1.81) 
Strict Parenting† 
 
1.03 
(0.96 - 1.10) 
1.02 
(0.95-1.09) 
1.32** 
(1.07 – 1.62) 
1.11 
(0.88-1.39) 
Frequent Childhood Religious 
Attendance† 
0.72*** 
(0.66 – 0.78) 
0.74*** 
(0.68-0.80) 
0.86 
(0.69 - 1.07) 
0.84 
(0.67-1.06) 
Childhood Sexual Abuse1 
 
1.25** 
(1.08 – 1.42) 
1.17* 
(1.01-1.34) 
1.98*** 
(1.49 – 2.64) 
1.35 
(0.95-1.92) 
Weekly Tobacco Use1 
 
210.17*** 
(5.00 – 20.71) 
28.57*** 
(3.93-18.68) 
3.98*** 
(3.12 – 5.07) 
2.76*** 
(2.10-3.64) 
Tobacco Dependence1 
 
1.82* 
(1.29 – 2.56) 
0.89 
(0.63-1.25) 
2.77*** 
(2.18 – 3.52) 
1.36* 
(1.04-1.78) 
Monthly Alcohol Use1 21.65 20.75 1.03 0.94 
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Covariate Transition to Cannabis Use Opportunity 
N = 3763 
Transition to Cannabis Dependence  
N = 3367 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
 
Unadjusted HR 
(95% CI) 
Adjusted HR 
(95% CI) 
 
(0.78 – 3.50) (0.34-1.64) (0.75 – 1.41) (0.69-1.30) 
Alcohol Dependence1 
 
1.79*** 
(1.29 – 2.48) 
1.26 
(0.89-1.78) 
22.94*** 
(1.69 – 5.12) 
2.64*** 
(1.53-4.58) 
Other Drug use1 1.31** 
(1.05 – 1.65) 
1.20 
(0.94-1.52) 
2.76*** 
(2.22 – 3.42) 
2.10*** 
(1.64-2.69) 
Other Drug Dependence1 
- - 
5.70*** 
(4.77 – 10.94) 
2.75*** 
(1.70-4.43) 
*P < 0.05  **P<0.01  ***P <0.001  
Note: Cannabis dependence N=363 (due to missing covariate data) 
HR= Hazard Ratio.    
1=Time Varying Covariate.    
2=Interaction with _t included in the model to account for breach of the proportional hazards assumption 
† When participant was aged 6 – 13 years old. 
